Skip to main content
OpenTrials
Completed

NCT Number: NCT01206673

Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease

The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nantes Hospital, Nantes, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (age equal or above 18.
  • Patients with Gaucher 's disease treated in the "Grand Ouest" competence center
  • patients affiliated to social security
  • Informed consent signed

Exclusion criteria

  • Children (age<18)

Treatment and study plan

Blood sampling

Other

One blood sampling is required for the research

Primary outcomes

  1. To determine the implication of acquired and inherent immunity in the Gaucher's clinical phenotype at moment of blood sampling

Secondary outcomes

  1. to find new activity mark for Gaucher's disease by studying macrophagic activation's markers.

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

Evaluation of Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease.

Acronym: Gaucher

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Sep 22, 2010
Registry last updated
Dec 2, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.